We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Groundbreaking Procedure Combines New Treatments for Liver Tumors

By HospiMedica International staff writers
Posted on 08 Dec 2025

Removing or destroying liver tumors often requires patients to undergo two separate procedures, exposing them to multiple hospital stays, repeated anesthesia, and longer recovery times. More...

Traditional approaches also rely on less precise techniques when CT imaging is not available in the operating room, limiting accuracy when tumors are hard to reach. Now, a new approach combines robotic liver resection and CT-guided ablation in a single operation to reduce patient burden and improve precision.

This combined procedure was developed and performed at Amsterdam UMC (Amsterdam, Netherlands), where teams integrated robotic surgery with CT-guided interventional oncology workflows inside a hybrid operating room. The method brings together two standard liver tumor treatments—robot-assisted resection and image-guided ablation—within one tightly coordinated surgical session. CT guidance allows real-time visualization of tumor targets during ablation, while robotic instruments support highly controlled liver resection.

During the procedure, surgeons removed tumor tissue robotically and then used CT imaging to guide heat-based ablation of additional lesions, ensuring complete coverage while preserving healthy liver tissue. This dual-modality approach reduces the need for large incisions and avoids staging the treatments separately. Initial use of the technique followed months of preparation, ensuring safe integration of surgical and interventional teams.

A clinical study is now underway at Amsterdam UMC to evaluate safety, feasibility, and early outcomes in 15 patients with liver tumors. The goal is to compare the single-session method with standard, separate procedures to determine its benefits in recovery time, complication rates, and overall effectiveness. Depending on the results, a larger multicenter trial involving additional UMCs is planned.

Performing both treatments at once can significantly reduce strain on patients by avoiding repeat anesthesia and hospital admissions, while advanced ablation technologies can improve precision. The researchers expect this new treatment will become accessible to all patients with liver tumors within three years.

"Until now, these procedures could only be done separately or with less precise techniques through a large incision in the abdomen or traditional laparoscopic surgery without a CT scanner,” said Rutger-Jan Swijnenburg, MD, liver surgeon at Amsterdam UMC and co-developer of the combined procedure. “The patient had to undergo two separate hospital stays and receive anesthesia twice. By performing both procedures within one operation, we minimize the burden on the patient."

Related Links:
Amsterdam UMC


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.